Alerts will be sent to your verified email
Verify Email
ADVENZYMES
|
Advanced Enzyme
|
Fermenta Biotech
|
Concord Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
7.5 % | 3.99 % | 2.26 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.01 % | 2.37 % | 20.02 % |
|
5yr average Equity Multiplier
|
1.16 | 1.97 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 0.54 | 0.52 |
|
5yr Avg Net Profit Margin
|
24.34 % | 2.96 % | 30.81 % |
|
Price to Book
|
2.39 | 2.64 | 10.03 |
|
P/E
|
24.07 | 21.59 | 48.87 |
|
5yr Avg Cash Conversion Cycle
|
87.24 Days | 23.64 Days | 37.41 Days |
|
Inventory Days
|
72.86 Days | 138.41 Days | 80.96 Days |
|
Days Receivable
|
58.11 Days | 60.61 Days | 111.87 Days |
|
Days Payable
|
50.65 Days | 136.91 Days | 173.13 Days |
|
5yr Average Interest Coverage Ratio
|
54.91 | 1.68 | 137.55 |
|
5yr Avg ROCE
|
16.0 % | 8.67 % | 25.59 % |
|
5yr Avg Operating Profit Margin
|
38.48 % | 14.59 % | 42.97 % |
|
5 yr average Debt to Equity
|
0.02 | 0.63 | 0.04 |
|
5yr CAGR Net Profit
|
0.61 % | n/a | 12.77 % |
|
5yr Average Return on Assets
|
10.35 % | 1.31 % | 15.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.08 % | 64.09 % | 44.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-9.62 % | 4.51 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.1 % | 0.0 | -0.42 % |
|
Advanced Enzyme
|
Fermenta Biotech
|
Concord Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|